News | Molecular Imaging | June 29, 2015

North America Accounts for Highest Share of Global Nuclear Medicine Diagnostic Market

Fusion imaging and wide availability of radiopharmaceuticals expected to push market up nearly $7 billion by 2019

nuclear medicine diagnostic market, North America, PET, SPECT, Mordor

June 29, 2015 - The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North America accounts for the highest share of the global nuclear medicine diagnostic market, followed by Europe and Asia-Pacific. Asian countries are expected to show a growing trend in the diagnostic sector because of increasing diagnostic procedure demand and the rise of the medical device industry.

The market is segmented into two major segments: single photon emission computed tomography (SPECT), which includes technetium-99m (TC-99m), thallium-201 (TL-201), iodine (I-123) and others; and positron emission tomography (PET), including fluorine-18, rubidium-82 (RB-82) and others. By application the market is segmented into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others). By geography the market is segmented into North America, Europe and Asia-Pacific etc.

The global nuclear medicine diagnostic (PET and SPECT) market is expected to grow from an estimated $ 8.77 billion in 2014 to $15.51 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.08 percent.

Major factors for the growth of the market are increasing use of SPECT and PET in medical diagnostics, increased awareness about radiopharmaceuticals and ready availability of radiopharmaceuticals. It has novel applications for diseases such as Alzheimer's and a continually expanding oncology segment. However, some of the major constraints for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues.

Until now, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to flip upside down because of a global shortage of molybdenum-99 isotope, which in turn will lead to a shortage of technetium-99, the daughter product of molybdenum. Hence, PET imaging products, which includes hybrid PET-CT scanners, holds a potential increase in market size in coming years. The cost associated with PET-CT service contracts is usually 105 percent of the system purchase price annually and can be as high as $275,000 per year.

The emerging market trend is fusion of nuclear imaging with different diagnostic imaging products such as PET/CT, SPECT/CT, and MRI/PET (magnetic resonance imaging). This provides a full gamut of imaging scans through the same unit and at the same time. The PET market is expected to witness more growth compared to SPECT imaging, as it provides higher resolution images, and the lack of availability of technetium-99m is propelling the industry to look for alternative diagnostic procedures.

Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging. SPECT, however, is mostly being used in the cardiology segment, accounting for almost 90 percent of the market share in cardiology. North America has totaled 5,729 PET procedures, while the number of PET procedures in the Asia-Pacific region is 369,636, owing to the increased demand of nuclear medicine diagnostic procedures in developing nations.

Major players in the market include Cardiarc Ltd., Digirad Corp., Gamma Medica Inc., GE Healthcare and Hologic Inc. Mergers and acquisitions of small and medium-sized manufacturers is another strategy being adopted by multinational players to enter in overseas markets.

For more information: www.mordorintelligence.com

Related Content

PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Overlay Init